2seventy bio's market cap is currently ―. The company's EPS TTM is $-4.413; its P/E ratio is -1.02; 2seventy bio is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 12.03M	$ 5.02M	$ 12.25M	$ 41.13M	$ 13.41M
Gross Profit	$ 11.48M	$ 9.72M	$ 7.95M	$ 26.92M	$ 13.03M
EBIT	$ -71.64M	$ -42.09M	$ -47.02M	$ -24.65M	$ -68.32M
EBITDA	$ -68.88M	$ -39.85M	$ -44.77M	$ -22.33M	$ -65.94M
Net Income Common Stockholders	$ -71.64M	$ -42.09M	$ -47.02M	$ -23.14M	$ -67.88M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 250.62M	$ 282.84M	$ 193.63M	$ 266.27M	$ 323.11M
Total Assets	$ 640.81M	$ 705.71M	$ 742.44M	$ 656.66M	$ 708.74M
Total Debt	$ 260.16M	$ 263.58M	$ 414.69M	$ 270.17M	$ 273.29M
Net Debt	$ 9.54M	$ -19.26M	$ 221.06M	$ 3.90M	$ -49.82M
Total Liabilities	$ 334.38M	$ 338.22M	$ 341.11M	$ 346.20M	$ 385.56M
Stockholders Equity	$ 306.42M	$ 367.50M	$ 401.32M	$ 310.47M	$ 323.18M
Cash Flow	-
Free Cash Flow	$ -24.18M	$ -36.70M	$ -55.22M	$ -58.57M	$ -74.35M
Operating Cash Flow	$ -21.43M	$ -32.73M	$ -49.14M	$ -55.40M	$ -60.93M
Investing Cash Flow	$ 15.93M	$ -64.83M	$ 44.87M	$ -532.00K	$ -82.29M
Financing Cash Flow	$ -75.00K	$ 128.00K	$ 127.08M	$ 232.00K	$ 175.00K

Currency in USD

2seventy bio Earnings and Revenue History

Income Statement >

2seventy bio Debt to Assets

Balance Sheet >

2seventy bio Cash Flow

Cash Flow >

2seventy bio Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing